UBS lowered the firm’s price target on Waters (WAT) to $370 from $395 and keeps a Neutral rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT:
- Waters price target lowered to $363 from $398 at Baird
- Waters price target lowered to $373 from $400 at TD Cowen
- Waters resumed with an In Line at Evercore ISI
- Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside
- Waters price target lowered to $350 from $410 at BofA